Humana Options Trading: A Deep Dive into Market Sentiment

Financial giants have made a conspicuous bearish move on Humana. Our analysis of options history for Humana HUM revealed 16 unusual trades.

Delving into the details, we found 37% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $760,175, and 7 were calls, valued at $259,940.

Latest Startup Investment Opportunities:

Expected Price Movements

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $375.0 to $475.0 for Humana during the past quarter.

Volume & Open Interest Trends

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Humana's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Humana's substantial trades, within a strike price spectrum from $375.0 to $475.0 over the preceding 30 days.

Humana Option Activity Analysis: Last 30 Days

Significant Options Trades Detected:

About Humana

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

In light of the recent options history for Humana, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Where Is Humana Standing Right Now?

• With a volume of 636,603, the price of HUM is down -0.13% at $401.0.
• RSI indicators hint that the underlying stock may be oversold.
• Next earnings are expected to be released in 3 days.

What The Experts Say On Humana

5 market experts have recently issued ratings for this stock, with a consensus target price of $559.8.

• Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $597.
• Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Humana, targeting a price of $515.
• In a cautious move, an analyst from Truist Securities downgraded its rating to Hold, setting a price target of $550.
• An analyst from Oppenheimer has revised its rating downward to Outperform, adjusting the price target to $630.
• Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Humana with a target price of $507.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Humana, Benzinga Pro gives you real-time options trades alerts.